Summary - ARGX - NASDAQ - Weiss Ratings

E

argenx SE ARGX

$358.41 -$7.79-2.13%

Recommendation

Prev Close

Volume

Avg Vol (90D)

Market Cap

Dividend & Yield

--

52-Week Range

$327.73 - $550.76

P/E (TTM)

--

EPS (TTM)

My Lists My Alerts

Report

Rating

Reward

Risk

Rating Factors

Growth Index

Efficiency Index

Solvency Index

Total Return Index

Volatility Index

Dividend Index

--

Headlines

Analysts' Top Healthcare Picks: Elevance Health (ELV), Argenx Se (ARGX)

4/19/2024 - TipRanks Financial Blog

argenx SE (ARGX, $358.41) price may climb as it broke lower Bollinger Band on Apr 18, 2024

4/19/2024 - Tickeron - Stocks

argenx SE (ARGX, $366.2) RSI Indicator left the oversold zone on April 17, 2024

4/18/2024 - Tickeron - Stocks

argenx SE (NASDAQ:ARGX) Sees Large Drop in Short Interest

4/17/2024 - Zolmax

argenx Data Highlight Evidence that VYVGART and VYVGART Hytrulo Drive Transformative Outcomes for Patients with Debilitating Autoimmune Disease

4/16/2024 - Globe Newswire

Allspring Global Investments Holdings LLC Purchases 15,431 Shares of argenx SE (NASDAQ:ARGX)

4/13/2024 - Zolmax

Argenx Se (ARGX) Receives a Buy from Bank of America Securities

4/12/2024 - TipRanks Financial Blog

DAVENPORT & Co LLC Boosts Holdings in argenx SE (NASDAQ:ARGX)

4/9/2024 - Zolmax

argenx SE (NASDAQ:ARGX) Position Boosted by Raymond James Financial Services Advisors Inc.

4/5/2024 - Zolmax

UBS Reaffirms Their Hold Rating on Argenx Se (ARGX)

4/3/2024 - TipRanks Financial Blog

StoneCrest Wealth Management Inc. Takes Position in argenx SE (NASDAQ:ARGX)

4/1/2024 - Ticker Report

Values First Advisors Inc. Sells 998 Shares of argenx SE (NASDAQ:ARGX)

3/29/2024 - Ticker Report

Here's Why argenx SE (ARGX) Pulled Back 23% in Q4

3/29/2024 - Insider Monkey

Buy Rating Affirmed for Argenx Se on Efgartigimod Progress and Regulatory Success

3/29/2024 - TipRanks Financial Blog

argenx SE (NASDAQ:ARGX) to Post Q3 2024 Earnings of ($1.01) Per Share, Wedbush Forecasts

3/28/2024 - Ticker Report

Wall Street Analysts Are Bullish on Top Healthcare Picks

3/28/2024 - TipRanks Financial Blog

Analysts Offer Insights on Healthcare Companies: Moderna (MRNA), Argenx Se (ARGX) and NovoCure (NVCR)

3/28/2024 - TipRanks Financial Blog

Analysts Set argenx SE (NASDAQ:ARGX) Price Target at $530.42

3/28/2024 - Ticker Report

argenx Advances Clinical Development of Efgartigimod in Primary Sjogren's Disease

3/27/2024 - Globe Newswire

argenx Announces Annual General Meeting of Shareholders on May 7, 2024

3/26/2024 - Globe Newswire

Reaffirming Buy Rating for Argenx with New Price Objective Following Vyvgart's Approval in Japan

3/26/2024 - TipRanks Financial Blog

argenx SE (NASDAQ:ARGX) Shares Sold by SG Americas Securities LLC

3/26/2024 - Zolmax

Brokerages Set argenx SE (NASDAQ:ARGX) Target Price at $530.42

3/26/2024 - Zolmax

argenx Announces Approval of VYVGART (efgartigimod alfa) in Japan for Adults with Primary Immune Thrombocytopenia

3/26/2024 - Globe Newswire

argenx SE (NASDAQ:ARGX) Shares Sold by Oak Ridge Investments LLC

3/25/2024 - Zolmax

Income Statement

Total Revenue (TTM)

--

EBITDA (TTM)

--

EBIT (TTM)

--

Net Income (TTM)

--

Balance Sheet

Total Assets (Q)

Total Debt (Q)

Total Liabilities (Q)

Book Value Per Share (Q)

Cash Flow

Cash from Operations (TTM)

--

Cash from Investing (TTM)

--

Cash from Financing (TTM)

--

Net Change in Cash (TTM)

--

Filings

Filing Date

Thursday, March 21, 2024

Period Date

Sunday, December 31, 2023

Next Filing

Beginning of May (est)

Price History

Loading...

Beta

7-Day Total Return

30-Day Total Return

60-Day Total Return

90-Day Total Return

Year to Date Total Return

1-Year Total Return

2-Year Total Return

3-Year Total Return

5-Year Total Return

52-week Low

Dec 21, 2023 - $327.73

52-week High

Jul 21, 2023 - $550.76

Valuation

Market Cap

$21.48B - Large Cap

Enterprise Value

Price/Sales (TTM)

Price/Book (Q)

Dividends and Shares

Shares Outstanding

Dividend Per Share (Most Recent)

--

Dividend Per Share (TTM)

--

Corporate Info

Website

Phone Number

31 10 703 8441

Address

Laarderhoogtweg 25
Amsterdam, 1101EB

Country

Year Founded

Business Description

Sector

Industry

Pharmaceuticals, Biotechnology and Life Sciences

argenx SE, a biotechnology company, engages in the developing of various therapies for the treatment of autoimmune diseases in the United States, Japan, Europe, Middle East, Africa, and China... more